The Biostatistics Resource is a joint effort between Roswell Park Cancer Institute and the Department of Biostatistics at the University at Buffalo. The objective of the Biostatistics Resource is to be strategically involved in the design, implementation, and analysis of scientific data generated by CCSG program members. This includes the articulation of study objectives, statement of hypotheses, the derivation of appropriate designs and models for the cost effective achievement of a study's objectives, the assurance that modern and appropriate statistical methods are used, monitoring interim and final analyses, and assisting in the writing of abstracts and manuscripts. The expertise provided by the staff ensures that the yield of useful information from the scientific studies conducted at Roswell Park Cancer Institute is maximized while the costs are minimized. With Alan Hutson, PhD, Chair of Biostatistics at both the University at Buffalo and Roswell Park Cancer Institute, Gregory Wilding, PhD, Assistant Chair, and several newly appointed PhD and MS level biostatisticians, the Resource has improved dramatically with respect to its technical expertise. This expertise spans biostatistics, molecular epidemiology, bioinformatics and statistical genetics. Most Resource projects require the use of standard and commercially available tools. More recently, with the explosion of high throughput technologies, particular problems require an innovative solution for which the Resource develops novel methodology and/or custom software. Within the Biostatistics Resource, the Biotechnical, Analytic and Visualization Resource (BAVR), headed by Daniel Gaile, PhD, has been developed to spearhead software development for complex statistical genetics and bioinformatics problems. The Resource's expanded and enhanced capabilities are made known to CCSG Program leaders through referrals, by the Scientific Review Committee's requirement that protocols and grant applications have input from a biostatistician, the mandate by funding agencies that proposals include statistical designs with proper power analyses, formal seminars given by Resource staff, and presentations at Program meetings. Strong synergies have also developed in terms of the relationship with the Statistics and Data Coordinating center for the Gynecologic Oncology Group (GOG). In addition, the Resource has been a fertile ground for training graduate students in biostatistics. The Resource is used by all six Programs. $251,993 in CCSG support is requested, representing 22% of the total operating budget.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-33
Application #
7826841
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
33
Fiscal Year
2009
Total Cost
$857,677
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2018) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol 141:1028-1035
Dasgupta, Subhamoy; Rajapakshe, Kimal; Zhu, Bokai et al. (2018) Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature 556:249-254
La Shu, Shin; Yang, Yunchen; Allen, Cheryl L et al. (2018) Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep 8:12905
Zhang, Dingxiao; Tang, Dean G; Rycaj, Kiera (2018) Cancer stem cells: Regulation programs, immunological properties and immunotherapy. Semin Cancer Biol 52:94-106
Gabriel, Emmanuel; Attwood, Kristopher; Al-Sukhni, Eisar et al. (2018) Age-related rates of colorectal cancer and the factors associated with overall survival. J Gastrointest Oncol 9:96-110
Ma, Wen Wee; Xie, Hao; Fetterly, Gerald et al. (2018) A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients. Am J Clin Oncol :
Chen, George L; Carpenter, Paul A; Broady, Raewyn et al. (2018) Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant 24:373-380
Eng, Kevin H; Szender, J Brian; Etter, John Lewis et al. (2018) Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. PLoS Genet 14:e1007194
Barger, Carter J; Zhang, Wa; Sharma, Ashok et al. (2018) Expression of the POTE gene family in human ovarian cancer. Sci Rep 8:17136
Bucsek, Mark J; Giridharan, Thejaswini; MacDonald, Cameron R et al. (2018) An overview of the role of sympathetic regulation of immune responses in infectious disease and autoimmunity. Int J Hyperthermia 34:135-143

Showing the most recent 10 out of 1555 publications